Veterinary medicines manufacturers have started increasingly producing combination medicated feed additives to improve efficiencies of the end product. Medicated feed additives in general help maintain animal health and promote growth and feed efficiency. They are usually promoted as an extra nutrient or drug for livestock. Medicated feed additives include vitamins, amino acids, fatty acids, pharmaceuticals, minerals, growth hormones and fungus. Around 70% of companies in the medical feed additives market are introducing new medicated feed additives formed as a result of a combination of two or more medicated feed additives to improve the efficiency of the product. For instance, in November 2018, Zoetis, the world’s largest producer of veterinary medicines, received an approval from the US FDA (Food and Drug Administration) for Cyden and Lincomix, a combination feed additive proposed to be used as a medicated feed additive for poultry.
Chewable tablets are increasingly being used to prevent animals from being affected by ticks, worms, fleas and others. Such tablets are usually soft chew and are available in different flavors such as beef-flavored tablets. Treatments with these tablets are easier to administer than with regular tablets as they can be easily added to regular meals of animals. Many veterinary medicines manufacturers are constantly working towards producing effective and easy-to-give drugs to succeed in the highly consolidated animal medicine market. For instance, in July 2018, the US FDA approved NexGard (afoxolaner), a chewable tick tablet marketed by Boehringer Ingelheim, a German pharmaceutical company. The tablet kills certain black-legged ticks, as well as American dog ticks, lone star ticks, and brown dog ticks to prevent flea infections in dogs.
The global animal medicine market is expected to grow from $38 billion in 2019 to $61 billion in 2023 at a compound annual growth rate (CAGR) of 12.5%.
The animal medicine industry includes establishments that manufacture veterinary pharmaceuticals such as veterinary vaccines, veterinary antibiotics, and other veterinary pharmaceuticals, and establishments that manufacture medical feed additives and nutritional feed additives. Companies in the animal medicine industry are increasingly collaborating and partnering with other players to drive product innovations. To succeed in the increasingly competitive animal medicine market, veterinary medicines companies are entering into new geographies and developing innovative products through sharing skills and expertise with other players. In April 2019, Bayer AG, a German pharmaceutical and life sciences company, collaborated with Adivo GmbH, a biotech company generating therapeutic antibodies for companion animals, to develop therapeutic antibodies for veterinary medicine. Similarly, in June 2018, Merck & Co.’s subsidiary, MSD Animal Health, announced a strategic partnership with Vinovo B.V., a division of Viscon Hatchery Automation, a leading hatchery automation company, to provide a new standard in safe and effective in-ovo vaccination to improve bird welfare, reduce vaccine reactions and provide improved protection for poultry.